Paul K.S. Chan

46.8k total citations · 10 hit papers
603 papers, 29.7k citations indexed

About

Paul K.S. Chan is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Paul K.S. Chan has authored 603 papers receiving a total of 29.7k indexed citations (citations by other indexed papers that have themselves been cited), including 318 papers in Epidemiology, 245 papers in Infectious Diseases and 135 papers in Molecular Biology. Recurrent topics in Paul K.S. Chan's work include Respiratory viral infections research (104 papers), Influenza Virus Research Studies (99 papers) and SARS-CoV-2 and COVID-19 Research (91 papers). Paul K.S. Chan is often cited by papers focused on Respiratory viral infections research (104 papers), Influenza Virus Research Studies (99 papers) and SARS-CoV-2 and COVID-19 Research (91 papers). Paul K.S. Chan collaborates with scholars based in Hong Kong, China and United States. Paul K.S. Chan's co-authors include Joseph J.�Y. Sung, Nelson Lee, David S.C. Hui, Ka‐Fai To, Julian W. Tang, Alan Wu, Grace Lui, Martin C.W. Chan, Francis K.L. Chan and Winnie Yeo and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Paul K.S. Chan

593 papers receiving 28.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong

2003 1.9k citations Nelson Lee, David S.C. Hui et al. profile →
Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus

1998 814 citations Paul K.S. Chan et al. profile →
Use of convalescent plasma therapy in SARS patients in Hong Kong

2004 674 citations Paul K.S. Chan et al. profile →
Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises

2006 477 citations Paul K.S. Chan et al. profile →
Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong

2021 376 citations Ka Chun Chong, Rita W. Y. Ng et al. profile →
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome

2022 351 citations Qin Liu, Joyce Wing Yan Mak et al. Gut profile →
Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19

2020 342 citations Tao Zuo, Qin Liu et al. Gut profile →
Gut mucosal virome alterations in ulcerative colitis

2019 299 citations Tao Zuo, Chun Pan Cheung et al. Gut profile →
Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes

2018 266 citations Sunny H. Wong, Zigui Chen et al. profile →
Gut microbiome dysbiosis across early Parkinson’s disease, REM sleep behavior disorder and their first-degree relatives

2023 93 citations Paul K.S. Chan, Zigui Chen et al. Nature Communications profile →

Peers

Countries citing papers authored by Paul K.S. Chan

Since Specialization

Citations

This map shows the geographic impact of Paul K.S. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul K.S. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul K.S. Chan more than expected).

Fields of papers citing papers by Paul K.S. Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul K.S. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul K.S. Chan. The network helps show where Paul K.S. Chan may publish in the future.

Co-authorship network of co-authors of Paul K.S. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Paul K.S. Chan. A scholar is included among the top collaborators of Paul K.S. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul K.S. Chan. Paul K.S. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Changes in the Incidence and Human Papillomavirus-Positive Portion of Oropharyngeal Squamous Cell Carcinoma in Hong Kong 2024 ·Cancers ·Zigui Chen, Amy B. W. Chan, (unknown), (unknown), Jason Y. K. Chan, (unknown), Chit Chow, Siaw Shi Boon, (unknown), (unknown), (unknown), Rita W. Y. Ng, Wendy C. S. Ho, (unknown), Christopher K.C. Lai, Paul K.S. Chan	4
2	Early Metabolomic and Immunologic Biomarkers as Prognostic Indicators for COVID-19 2024 ·Metabolites ·Zigui Chen, Erik Fung, Chun Kwok Wong, Lowell Ling, Grace Lui, Christopher K.C. Lai, Rita W. Y. Ng, (unknown), Wendy C. S. Ho, David S.C. Hui, Paul K.S. Chan	2
3	Predictive evolutionary modelling for influenza virus by site-based dynamics of mutations 2024 ·Nature Communications ·(unknown), Weiwen Liang, (unknown), Inchi Hu, Shi Zhao, Zigui Chen, Renee W. Y. Chan, Peter Pak‐Hang Cheung, Hong Zheng, (unknown), (unknown), Ka Chun Chong, (unknown), Eng‐Kiong Yeoh, Paul K.S. Chan, Benny Zee, Chris Ka Pun Mok, Maggie Haitian Wang	6
4	Respiratory Viral Infection Patterns in Hospitalised Children Before and After COVID-19 in Hong Kong 2024 ·Viruses ·(unknown), (unknown), Stacy Lok Sze Yam, Kam‐Lun Ellis Hon, Paul K.S. Chan, Albert Martin Li, Renee W. Y. Chan	6
5	Early-Life Skin Microbial Biomarkers for Eczema Phenotypes in Chinese Toddlers 2023 ·Pathogens ·(unknown), (unknown), Zigui Chen, (unknown), Kate Ching Ching Chan, Agnes Sze Yin Leung, (unknown), (unknown), Lai Yuk Yuen, Paul K.S. Chan, Wing Hung Tam, Ting Fan Leung	2
6	Changes in all-cause and cause-specific excess mortality before and after the Omicron outbreak of COVID-19 in Hong Kong 2023 ·Journal of Global Health ·Ka Chun Chong, Paul K.S. Chan, Chi Tim Hung, Carlos King Ho Wong, Xi Xiong, Yuchen Wei, Shi Zhao, Zihao Guo, Huwen Wang, Carrie HK Yam, (unknown), (unknown), (unknown), (unknown), (unknown), Eng‐Kiong Yeoh, (unknown)	11
7	Characterization of upper airway microbiome across severity of COVID-19 during hospitalization and treatment 2023 ·Frontiers in Cellular and Infection Microbiology ·Lowell Ling, Christopher K.C. Lai, Grace Lui, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Wai‐Tat Wong, David S.C. Hui, Chun Kwok Wong, Paul K.S. Chan, Zigui Chen	3
8	Antibiotics and probiotics impact gut antimicrobial resistance gene reservoir in COVID-19 patients 2022 ·Gut Microbes ·Qi Su, Qin Liu, Lin Zhang, Zhilu Xu, Chen-Yu Liu, Wenqi Lu, Jessica Y. L. Ching, Amy Li, Joyce Wing Yan Mak, Grace Lui, Susanna S. Ng, Kai Ming Chow, David S.C. Hui, Paul K.S. Chan, Francis K.L. Chan, Siew C. Ng	10
9	Suppression of influenza virus infection by rhinovirus interference – at the population, individual and cellular levels 2022 ·Current Research in Microbial Sciences ·(unknown), Ka Chun Chong, Kathy Yuen Yee Chan, (unknown), (unknown), (unknown), Calvin S.H. Ng, (unknown), Paul K.S. Chan, Albert Martin Li, Renee W. Y. Chan	6
10	Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome 2022 ·Nature Communications ·Qin Liu, Qi Su, Fen Zhang, Hein M. Tun, Joyce Wing Yan Mak, Grace Lui, Susanna S. Ng, Jessica Y. L. Ching, Amy Li, Wenqi Lu, Chenyu Liu, Chun Pan Cheung, David S.C. Hui, Paul K.S. Chan, Francis K.L. Chan, Siew C. Ng	45
11	Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2 2021 ·Viruses ·Shi Zhao, (unknown), Ka Chun Chong, (unknown), Hong Zheng, Zigui Chen, Renee W. Y. Chan, Benny Zee, Paul K.S. Chan, Maggie Haitian Wang	21
12	Limited role for meteorological factors on the variability in COVID-19 incidence: A retrospective study of 102 Chinese cities 2021 ·PLoS neglected tropical diseases ·Ka Chun Chong, Jinjun Ran, Steven Yuk Fai Lau, William B. Goggins, Shi Zhao, Pin Wang, Linwei Tian, Maggie Haitian Wang, Kirran N. Mohammad, Lai Wei, Xi Xiong, (unknown), Paul K.S. Chan, Huwen Wang, Yawen Wang, Jingxuan Wang	7
13	Chemopreventive Role of Apigenin against the Synergistic Carcinogenesis of Human Papillomavirus and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone 2020 ·Biomedicines ·(unknown), Lijiao Zhao, Lili Zhang, Yuhe Chen, Guohui Sun, Jintao Li, Na Zhang, Yuancong Xu, Paul K.S. Chan, Rugang Zhong	7
14	Synergistic Effect between Human Papillomavirus 18 and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone on Malignant Transformation of Immortalized SHEE Cells 2019 ·Chemical Research in Toxicology ·(unknown), Jintao Li, Guohui Sun, (unknown), Na Zhang, Lijiao Zhao, Paul K.S. Chan, Rugang Zhong	5
15	Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome 2017 ·Gut ·Tao Zuo, Sunny H. Wong, Kelvin Lam, Rashid N. Lui, Kitty Cheung, Whitney Tang, Jessica Y. L. Ching, Paul K.S. Chan, Martin C.W. Chan, Justin CY Wu, Francis K.L. Chan, Jun Yu, Joseph J.�Y. Sung, Siew C. Ng	258
16	High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections 2013 ·Clinical Infectious Diseases ·Nelson Lee, Grace Lui, K. T. Wong, (unknown), (unknown), Jim Yee Him Chan, Janice Yu, Simon S. Wong, Kitty Wai Ying Choi, (unknown), Karry L. K. Ngai, David S.C. Hui, Paul K.S. Chan	255
17	Early detection of nasopharyngeal carcinoma by plasma Epstein‐Barr virus DNA analysis in a surveillance program 2013 ·Cancer ·K.C. Allen Chan, Emily C W Hung, John K. S. Woo, Paul K.S. Chan, (unknown), (unknown), (unknown), (unknown), Y.W. Chan, (unknown), (unknown), Ann D. King, Anthony T.�C. Chan, Andrew C. van Hasselt, Yuk Ming Dennis Lo	123
18	Acute Encephalopathy Associated with Influenza A Infection in Adults 2010 ·Emerging infectious diseases ·Nelson Lee, Chun Kwok Wong, Paul K.S. Chan, Niklas Lindegårdh, Nicholas J. White, Frederick G. Hayden, Edward Wong, Ka Sing Wong, Clive S. Cockram, Joseph J.�Y. Sung, David S.C. Hui	41
19	Clearance of dengue virus in the plasma‐derived therapeutic proteins 2008 ·Transfusion ·Yi-Wu Xie, Paul K.S. Chan, (unknown), (unknown), Ida Miu‐Ting Chu, (unknown), Jo L.K. Cheung, (unknown), (unknown), (unknown)	24
20	Unrelated umbilical cord blood transplantation in children: experience of the Hong Kong Red Cross Blood Transfusion Service. 2004 ·PubMed ·Chi Kong Li, (unknown), Ki Wai Chik, (unknown), Nelson L.S. Tang, Paul K.S. Chan, (unknown), (unknown), (unknown), (unknown), Patrick Man Pan Yuen	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact